Unvaccinated people are more likely to get COVID-19 and be hospitalized for it. Anthony Darrell didn’t think it could happen to him – even though his sister, a doctor at UT Southwestern, urged him to get the shot.
Is there anything you can say to a reluctant friend or family member to persuade them COVID-19 vaccination is the right choice for them? The short answer is: 'yes,' says UT Southwestern.
TRIKAFTA may give patients with cystic fibrosis hope for healthy pregnancies. Learn about the landmark clinical trial to analyze its safety from pregnancy through two years after delivery.
U.S #lungcancer rates have declined for decades, except in one group: Young adults who never smoked. UT Southwestern discusses what we know about the risks, as well as ongoing research to reveal more answers.
COVID-19 vaccines represent our best chance of ending the pandemic, but a strong current of resistance and disinformation is sabotaging the effort to protect people from the virus. UT Southwestern separates the vaccine myths from the realities.
With more people getting tested for COVID-19, which method is the best? And do I really need to get a test? Check out this quick comparison of the three main types of coronavirus detection tests, the methods, the speed of results, and their overall effectiveness.
More men are dying from COVID-19, and testosterone may be part of the explanation. In this MedBlog, UT Southwestern discusses the underlying causes of men's risk factors.
Wearing a mask to protect yourself and others against COVID-19 pandemic should be a no-brainer, but misinformation and mixed signals have created mask confusion. UT Southwestern separates the myths from the medical realities.
The global pandemic has created an insatiable appetite for information about COVID-19, but amid the torrent of media coverage the myths begin to rival realities. UT Southwestern addresses some of the questions and false hopes with facts firmly rooted in science.
A new 3-drug combo drug for cystic fibrosis has been approved by the FDA. TRIKAFTA offers life-changing treatment potential for approximately 90% of patients with the disease. In this MedBlog, discover who is eligible and how the drug works. Learn more.
